PENICILLAMINE
LEAD POISONING AGENTS · CYSTINURIA ·+2
LUPIN PHARMACEU
Drug class
Wilson's Disease Treatment Agents
Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper. Read more about Wilson's Disease Treatment Agents
24 drugs in this class 18 manufacturers
Drugs in Wilson's Disease Treatment Agents
PENICILLAMINE
LEAD POISONING AGENTS · CYSTINURIA ·+2
GRANULES PHARMA
GALZIN (zinc acetate)
ZINC, SYSTEMIC · WILSON'S DISEASE
ETON PHARMACEUT
TRIENTINE HCL
WILSON'S DISEASE TREATMENT AGENTS · WILSON'S DISEASE
NOVADOZ PHARMAC
DEPEN (penicillamine)
LEAD POISONING AGENTS · CYSTINURIA ·+2
Viatris Specialty
GALZIN (zinc acetate)
ZINC, SYSTEMIC · WILSON'S DISEASE
ETON PHARMACEUT
Filter & compare in the drug finder →
Opens the drug finder with Wilson's Disease Treatment Agents preselected. Add indication or manufacturer filters there.
Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper.
Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc formulations that induce intestinal metallothionein to block gastrointestinal copper absorption.
Together, these agents serve to deplete toxic tissue copper stores and prevent re-accumulation, thereby mitigating progressive hepatic, neurologic, and psychiatric complications.
-
wilsondisease.org
Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc fo...
-
mdpi.com
Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper Together, these agents serve to deplete toxic tissue copper stores and prevent re-accumulation, thereby mitigating progressive hepatic, neurologic, and psychiatric complications
-
nih.gov
Wilson's disease treatment agents are a therapeutic group of medications indicated for the management of Wilson's disease, a rare autosomal recessive genetic disorder characterized by impaired biliary excretion and toxic systemic accumulation of copper Together, these agents serve to deplete toxic tissue copper stores and prevent re-accumulation, thereby mitigating progressive hepatic, neurologic, and psychiatric complications
-
nih.gov
Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc formulations that induce intestinal metallothionein to block gastrointestinal copper absorption
-
nih.gov
Rather than functioning through a single pathway, this therapeutic class encompasses systemic copper-chelating agents, such as penicillamine and trientine salts, which bind circulating copper to promote its renal excretion, as well as oral zinc formulations that induce intestinal metallothionein to block gastrointestinal copper absorption
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.